Article info
PDFClinical science
Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration
- Correspondence to Dr Jay Chhablani, LV Prasad Eye Institute, Banjara Hills, Road no. 2, Hyderabad, Telangana 500034, India; jay.chhablani{at}gmail.com
Citation
Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration
Publication history
- Received November 28, 2016
- Revised December 13, 2016
- Accepted December 19, 2016
- First published January 24, 2017.
Online issue publication
August 23, 2017
Article Versions
- Previous version (24 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/